Multiple Myeloma
Multiple Myeloma
We’re here for you. Call us at 844-346-7222 or
find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
33
Clinical Trials
Multiple Myeloma
Phase II
Accepting Patients
nct/study# NCT03601078 / BB2121-MM-002
A Phase 2, Multi-Cohort, Open-Label, Multicenter Study To Determine The Efficacy And Safety Of BB2121 In Subjects With Multiple Myeloma (Karmma-2)
Learn More
Multiple Myeloma
NA
Active
nct/study# NA / DAH-C-21-USA-003
A Retrospective Chart Review Of Daratumumab In Actively Diagnosed Multiple
Learn More
Multiple Myeloma
Phase I/II
Active
nct/study# NA / LAVA-051
A Phase 1 And 2a Open-Label Study To Evaluate The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity And Antitumor Activity Of LAVA-051 In Patients With Relapsed Or Refractory CD1d-Positive Chronic Lymphocytic Leukemia, Multiple Myeloma Or Acute Myeloid Leukemia
Learn More
Multiple Myeloma
Phase I
Active
Multiple Myeloma
Phase 1/2
Active
nct/study# NA / CP-NEXI-002-01
A Phase 1 / 2 Study To Evaluate The Safety And Tolerability Of Adoptively Transferred Autologous T Cells In Patients With Relapsed Refractory Multiple Myeloma
Learn More
Multiple Myeloma
NA
Active
nct/study# NA / 2021-0704
Safety Of Switching From Intravenous Daratumumab To Subcutaneous Daratumumab In Patients With Multiple Myeloma
Learn MoreWe are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.